Eruptive nevi associated with medications (ENAMs).
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27241804.
- Also identified by DOI 10.1016/j.jaad.2016.04.064.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Eruptive melanocytic nevi have been reported in association with severe blistering diseases, renal transplantation, malignancy, AIDS, and medications. Eruptive nevi associated with medications have been reported with increasing frequency. Of particular interest are eruptive nevi associated with medications developing in association with biologic therapies, which we anticipate will continue to become more common as use of these medications continues to increase. We searched the databases PubMed/MEDLINE, Cochrane, and Cumulative Index to Nursing and Allied Health Literature for associated medications using the terms "eruptive nevi," "melanocytic + medications," and "nevi + medications" for relevant articles. We report the summary of our findings, which were used in defining what constitutes an eruptive nevi associated with medication and developing a classification system by medication type.
Medical subject headings
- Antibodies, Monoclonal
- Antineoplastic Agents
- Drug Eruptions
- Immunosuppressive Agents
- Neoplasms, Multiple Primary
- Nevus, Pigmented
- Skin Neoplasms